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Expression of c-myc proto oncogene is regulated by multiple mechanisms. Here, we report that the consensus of the regulatory region of interferon- 
dependent genes, GGAAANI_3 GAAA, was found after computer search in the S-terminal flank of human c-myf gene in position (-76: -67). 
In vitro transcription of omyc gene fragments howed that the consensus region com@es with oligonucleotide GGGAAAATGAAACT for binding 
to specific protein(s). This oligonucleotide was shown to bind selectively the interferon-dependent positive transcription factor [l]. Transcription 
of c-myc fragments lacking S-terminal region up to positions - 101 or +71 was initiated at two sites located in the first intron. These sites did 
not coincide with P1 in vivo RNA cap-site. Binding of the protein factor(s) to the regulatory region of c-myc gene - 76: - 67 blocked the in vitro 
transcription initiated in the first intron. 
c-myc gene; In~~e~n-de~ndent gene; T~~~ption 
1. INTRODUCTION 
At present, the gene family induced by LY-. @- or ‘y- 
interferons (IFN) has been described [2]. These genes 
contain a similar nucleotide sequence in the 5’-terminal 
nontranscribing regions presumably involved in the 
IFN-dependent activation of transcription. Originally 
this sequence was detected in the HLA and metallothio- 
nein genes 131, and then in the number of IFN- 
dependent genes; it was termed as interferon response 
sequence (IRS). In addition, IRS consensus was found 
also in the regulatory part of /?-IFN gene (Table I). 
Table I 
The sequence of interferon-d~endent genes in the IRS (interferon 
response sequence) region 
Gene (human) Sequence Ref. 
F/S consensus GAP A CGA GAAA CT 3 
Factor B GGAAA CA- GAAA CT 4 
ISGlS GGAAA CC- GAAA CT 5 
ISG54 GGAAA GT- GAAA CT 5,ti 
IF156 GGAAA CT- GAAA GG 6 
IP-10 GGAAA GT- GAAA CT I 
6-16 GGAAA AT- GAAA CTa 1 
2’,5’ oligo-Asynthetase GGAAA C- - GAAA CC 8,9 
&IFN GGAAAACT GAAAG 10 
Consensus GGAAA N1.m3 GAAA 
’ This sequence is present twice in the gene 6-16 
Correspondence address: N.M. Alexandrova, Engelhardt Institute of 
Molecular Biology, USSR Academy of Sciences, Moscow 117984. 
USSR 
The first goal of this investigation was a computer 
search of databanks to find regions of other human 
genes that contain the IRS consensus. The IRS consen- 
sus proposed here (Table I) had been used. These se- 
quences were found in a few genes (see below) including 
c-myc gene. Hence, the second goal of the present work 
was to analyze functions of c-myc gene region contain- 
ing IRS consensus. 
2. MATERIALS AND METHODS 
2.1. Computer search for IRS consensus 
The GGAAAN,_,GAAA consensus was searched in the 10th 
release of the EMBL nucleotide databank (1986) and in the first 
release of the USSR ‘Gene-Express’ databank (1988) among human 
sequences. 
2.2. Plasmid construction and isolation 
Plasmid pUMC1 (Fig. 1) containing human c-myc -101: 1185 
region was constructed by inserting the SmaI/XbaI fragment of 
10 kbp human c-myc plasmid [ll] into the pUSVLcat vector (kind 
gift of Dr Archipova, Inst. of Molecular Biology, Acad. Sci. USSR, 
Moscow). Piasmids were isolated by the standard technique [12]; the 
DNA isolated was purified by centrifugation in CsCl gradient. 
2.3. HeLa S3 cell extract 
The total extract of HeLa S3 cells was prepared as described [13]. 
2.4. Tru~r~ption 
Transcription of linearized plasmid DNA in vitro was carried out 
as described by Hames and Higgins [14]. RNA transcripts were 
isolated using guanidine isothiocyanate [IS] and analyzed by elec- 
trophoresis in agarose gel in the presence of glyoxal [16]. The incuba- 
tion mixture contained (if mentioned) the double-stranded 
oligonucleotides GGGAAAATGAAACT (‘normal’) or GGGAA- 
AATGGACACT ~‘mutant’). Both oligonucl~tides were added into 
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Fig. 1. Scheme of hybrid c-myc/CAT plasmid pUMC1. Empty box 
indicates the first exon of the human c-myc gene, and solid box 
stands for CAT gene (fragment of pUSVLcat vector). Thin lines 
indicate the first c-myc intron and the upstream noncoding region of 
the gene. Restriction sites are marked as follows: S, SmaI; X, XhoI; 
XB, XbaI; R, EcoRI. Arrows indicate the initiation sites of 
transcription controlled by Pi and P2 promoters. The nucleotide 
positions for c-myc are defined relative to Pi site. 
the mixture at lo- or lOO-fold molar excess over plasmid DNA 
content. 
2.5. Synthesis of oligonucleotides 
Oligonucleotides were synthesized by solid phase phosphoramidite 
method using Beckman System I plus DNA synthesizer at 0.2 pmol 
scale and purified by reversed-phase HPLC on Ultrasphere-ODS 
column. 
3. RESULTS AND DISCUSSION 
3.1. Computer search for IRS consensus among the 
human gene sequences 
We have found 9 sites matching the GGAA- 
AN,-3GAAA consensus in the human sequences 
available to us; these sites have been located in 
regulatory regions of the following genes: c-myc [17], 
thyroglobulin [ 181, IGF-1 [ 191, prointerleukin-lfl [20], 
e-globin [21], preproencephalin [22], ,&globin [23], H, 
immunoglobulin chain [24], prolactin [25]. Besides, 
these sites were found in a number of genes of IFN- 
inducible proteins and &IFN (this result is in good 
agreement with the data of Table I). 
3.2. Location of IRS consensus equence in the human 
c-myc gene 
The IRS consensus in human c-myc was positioned in 
nontranscribed part of the gene, -76: -67 (+ 1 position 
means the cap-site corresponding to Pr promoter; see 
[26]). The sequence of this region is the following: 
-80 -60 
gene: TGGGGGAAAAGAAAAAAGATC 
consensus: GGAAANGAAA 
In addition, 3 similar sites with one mismatch were 
found in the transcribing part of the gene, namely, in 
first exon and first intron; their positions are 100: 110, 
766:777 and 1574: 1585. 
3.3. In vitro transcription 
plasmids 
To investigate a potential 
68 
of the c-myc-containing 
Fig. 2. In vitro transcription of the pUMC1 plasmid cut with XbaI. 
(A) Scheme of the transcribed DNA and RNA (length of RNA is 
marked); solid box means the IRS consensus, arrows show the RNA 
obtained. (B) Electrophoresis of RNA synthesized (in 1.5% agarose 
gel); lo-fold (line l), lOGfold (line 2) excess of the (‘normal’) 
oligonucleotide, without added oligonucleotide (line 3), IO-fold (line 
4), lOO-fold (line 5) excess of ‘mutant’ oligonucleotide. Positions of 
marker DNA fragments (EcoRI-Hind111 digest of A phage DNA and 
regulatory function(s) of MspI one of pBR-322 plasmid DNA) are shown. 
the IRS-like sequences of the c-myc gene we have used 
a technique of in vitro transcription with HeLa S3 cell 
extract; plasmid pUMC1 (Fig. 1) was a template DNA. 
We run in vitro transcription either with or without 
the competing oligonucleotide, GGGAAAATGAAA- 
CT (IRS consensus is underlined). As it was shown, this 
oligonucleotide binds to the human IFN-dependent 
transcription factor [ 11; moreover, similar GGGAA- 
AATGAEACT oligonucleotide with the single 
mismatch (shown by asterisk) does not bind to this fac- 
tor. We have used both oligonucleotides referred here 
as ‘normal’ and ‘mutant’, respectively. 
Plasmid pUMC1 was cleaved with XbaI restriction 
endonuclease to linearize DNA for transcription. In the 
absence of the competing oligonucleotide in incubation 
mixture the RNA synthesized was nonspecific, pro- 
bably due to random initiation of RNA synthesis. Con- 
trary to this, addition of the oligonucleotide to the 
incubation mixture, resulted in appearance of specific 
RNA products (Fig. 2); when lOO-fold excess of the 
oligonucleotide over plasmid DNA was added, only the 
specific initiation of RNA synthesis was observed 
(Fig. 2): two main products were detected of about 410 
and 300 nucleotides long. It is noteworthy that the ac- 
tivity of the ‘mutant’ oligonucleotide was about lo-fold 
lower than the ‘normal’ one. 
Thus, addition of the specific oligonucleotide 
A Icat\ 
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Fig. 3. In vitro transcription of the c-mytlCAT XhoI-EcoRI 
fragment of pUMC1 plasmid. (A) Scheme of the transcribed DNA 
and RNA (length of the RNA is marked); solid box is the IRS 
consensus, arrow shows the RNA obtained. (B) Electrophoresis of 
RNA synthesized (in 1.5% agarose gel); IO-fold (line I), lOO-fold 
(line 2) excess of the (‘normal’) oligonucleotide, without added 
oligonucleotide (line 3), lo-fold (line 4), lOO-fold (line 5) excess of 
‘mutant’ oligonucleotide. Marker DNA is shown (see legend to 
Fig. 2). 
presumably causes the redistribution of the transcrip- 
tion factor(s) that leaves the c-myc regulatory regions 
and binds to the oligonucleotide competitor. ‘Opening’ 
of the c-myc regulatory regions causes initiation of 
RNA transcription at the specific initiation sites. 
However, these sites do not coincide with the known 
transcription starts, Pi and PZ [26]. These new sites, 
referred as Ii and Iz, are situated in the first intron of 
human c-myc gene ca. 410 and 300 nucleotides 
upstream of the X&I site (Fig. 2). 
To check the assumption that binding of a transcrip- 
tion factor(s) to -76: -67 site of c-myc takes place, 
and to confirm that the synthesized RNA was initiated 
at the II site rather than being a product of a premature 
termination, we have also used the pUMC1 fragment 
71: 1435 (XhoIIEcoRI). In this experiment it turned 
out that the main RNA product is ca. 660 nucleotides 
long (Fig. 3); hence, the RNA is in fact initiated at Ii 
site (its position is ca. 775) and terminated in a standard 
run-off manner. The oligonucleotide addition caused 
an enhancement of transcription (Fig. 3), but RNA 
product was synthesized both with and without com- 
petitive oligonucleotides. Thus, if the -76: -67 frag- 
ment is present, the specific transcription becomes 
possible after dissociation of negative regulatory fac- 
tar(s). If this fragment is deleted, the transc~ption 
becomes constitutive. This finding has confirmed the 
interpretation proposed above our data. An enhance- 
ment of transcription of the DNA fragment lacking the 
-76 : -67 sequence (Fig. 3 lines 1,2,4,5) may be caus- 
ed by 100: 110 region of the gene; factor(s) that 
associates with the IRS consensus and affects the 
transcription could presumably bind (see above) to this 
region. 
Finally, we believe that the data presented provide 
good evidence that the IRS-like sequence of human c- 
myc gene makes it possible to affect its expression via 
binding of regulatory proteins including IFN- 
dependent factor(s). 
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